The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
MRC Molecular & Cellular Medicine Board (MCMB) New Investigator Research Grants, 2021
Open date: 9 Mar 2021
Deadline for applications: 5 May 2021 16:00 (UK+1)
The New Investigator Research Grant (NIRG) is aimed at researchers who are capable of becoming independent Principal Investigators and who are now ready to take the next step towards that goal. A NIRG is normally of three years duration. The scheme does not cover research involving trials of clinical treatments.
The Molecular and Cellular Medicine Board is responsible for MRC’s investments seeking to understand the molecular and cellular mechanisms that underpin complex biological function in human health and disease, and supporting the early translation of knowledge towards new diagnosis and treatment, and changes to policy and practice. The Board seeks to extend our understanding of structure-function insights of molecules and complexes, how the cellular environment functions during development and mature states, and how biological systems respond to external insults (e.g. drugs and toxins) and disease states. The Board leads MRC’s investments in cancer, from fundamental discovery science to epidemiology, experimental medicine and early translation.
Who can apply?
To be considered suitable for the scheme, applicants should be able to clearly demonstrate that their skills and experience at the time of their application match those of the transition to independence career stage, as set out in the Applicant skills and experience table.
There are no eligibility rules based on years of post-doctoral experience. The minimum formal qualification required is a graduate degree. Most applicants are also expected to have a PhD or an MD.
For the full call text please visit the MRC grant call webpage.